These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25956075)

  • 61. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI.
    Williams RO; Patel AM; Barron MK; Rogers TL
    Drug Dev Ind Pharm; 2001 May; 27(5):401-12. PubMed ID: 11448047
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
    D'Sa DJ; Lechuga-Ballesteros D; Chan HK
    Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
    McCabe JC; Koppenhagen F; Blair J; Zeng XM
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation.
    Trotta V; Lee WH; Loo CY; Haghi M; Young PM; Scalia S; Traini D
    Int J Pharm; 2015 Aug; 491(1-2):190-7. PubMed ID: 26117190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler.
    Hirst PH; Pitcairn GR; Richards JC; Rohatagi S; Gillen MS; Newman SP
    J Aerosol Med; 2001; 14(2):155-65. PubMed ID: 11681648
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of a novel digital breath-activated inhaler: Initial particle size characterization and clinical testing.
    Kesten S; Israel E; Li G; Mitchell J; Wise R; Stern T
    Pulm Pharmacol Ther; 2018 Dec; 53():27-32. PubMed ID: 30201410
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
    Berry J; Kline LC; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.
    Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
    AAPS PharmSciTech; 2009; 10(1):243-51. PubMed ID: 19280348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An Exploration of Factors Affecting
    Ruzycki CA; Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):405-417. PubMed ID: 31418632
    [No Abstract]   [Full Text] [Related]  

  • 77. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
    Walenga RL; Longest PW
    J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
    Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
    Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.